Skip to the page

Data / Form D filings / vTv Therapeutics Inc.

vTv Therapeutics Inc.: Form D filings

vTv Therapeutics Inc., a pharmaceuticals company in High Point, NC, filed 7 Form D notices with the SEC between 2017 and 2024. The latest, on March 7, 2024, reports $51 million sold of a $51 million offering to 4 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
3980 PREMIER DR, SUITE 310, High Point, NC, 27265
Phone
(336) 841-0300
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1641489

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 7, 2024New notice$50,961,457$50,961,4574Feb 27, 2024sec.gov
Jan 17, 2020New notice$10,000,000$2,000,000$8,000,0000Jan 7, 2020sec.gov
Oct 15, 2019New notice$10,000,000$2,000,000$8,000,0000Sep 27, 2019sec.gov
Jul 9, 2019New notice$9,000,000$4,000,000$5,000,0000Jun 25, 2019sec.gov
Jan 4, 2019New notice$10,000,000$1,500,000$8,500,0000Dec 27, 2018sec.gov
Aug 10, 2018New notice$10,000,000$0$10,000,0000Yet to occursec.gov
Dec 19, 2017New notice$10,000,000$10,000,0001Dec 5, 2017sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Keith A. HarrisDirector
Steven J. TuchExecutive Officer
Srinivas L. AkkarajuDirector
Raymond A. CheongDirector
Richard L. NelsonExecutive Officer, Director
Paul J. SekhriExecutive Officer, Director
John A. FryDirector
Fahed L. Al MarzooqiDirector
Howard L. WeinerDirector

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of Mar 4, 2024 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what vTv Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.